Case Studies
IRC – 409A Valuation of Common Stock
The Company: A biotechnology company (the “Company”) engaged in the development of an Influenza vaccine as its flagship product with others in the pipeline. The lead drug was in the pre-clinical phase of development, as of the date of valuation. The Company had raised...
ASC – 815 Valuation of Complex Securities
Instruments: Complex securities and embedded derivatives such as convertible debt, profit interests, preferred warrants, purchase options, securities that have unique characteristics, as mentioned below. Characteristics (indicative list): Warrants convertible in next...
ASC – 805 Purchase Price Allocation
The Deal: Company A / The Acquirer (Company): The acquirer is a provider of interactive technology products like large-format displays and collaboration software. Company B / The Target: The target company develops software applications for use with multi-touch...



